Efficacy and Safety of Bevacizumab Combined With First-Line Chemotherapy in Elderly (≥75 Years) Patients With Metastatic Colorectal Cancer: A Real-World Study. [electronic resource]
Producer: 20210906Description: e100-e109 p. digitalISSN:- 1938-0674
- Age Factors
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bevacizumab -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Female
- France -- epidemiology
- Geriatric Assessment -- statistics & numerical data
- Hemorrhagic Stroke -- chemically induced
- Humans
- Male
- Mesenteric Ischemia -- chemically induced
- Progression-Free Survival
- Prospective Studies
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.